Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

COLL

Collegium Pharmaceutical (COLL)

Collegium Pharmaceutical Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:COLL
DateTimeSourceHeadlineSymbolCompany
01/14/20254:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
01/10/20254:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
01/08/20258:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
01/08/20258:00AMGlobeNewswire Inc.Collegium Provides 2025 Financial Guidance and Business UpdateNASDAQ:COLLCollegium Pharmaceutical Inc
11/14/20244:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
11/14/20244:49PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
11/12/20248:00AMGlobeNewswire Inc.Collegium to Participate in Upcoming Investor ConferencesNASDAQ:COLLCollegium Pharmaceutical Inc
11/07/20244:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:COLLCollegium Pharmaceutical Inc
11/07/20244:02PMGlobeNewswire Inc.Collegium Reports Record Third Quarter 2024 Financial ResultsNASDAQ:COLLCollegium Pharmaceutical Inc
11/07/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
11/07/20244:01PMGlobeNewswire Inc.Collegium Appoints Vikram Karnani as Chief Executive OfficerNASDAQ:COLLCollegium Pharmaceutical Inc
10/24/20248:00AMGlobeNewswire Inc.Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024NASDAQ:COLLCollegium Pharmaceutical Inc
09/17/20244:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
09/13/202410:39AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
09/13/202410:06AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
09/06/20245:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
09/06/202411:53AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
09/05/20244:47PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
09/04/20248:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
08/30/20248:00AMGlobeNewswire Inc.Collegium to Participate in H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:COLLCollegium Pharmaceutical Inc
08/28/20248:00AMGlobeNewswire Inc.Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024NASDAQ:COLLCollegium Pharmaceutical Inc
08/15/20244:05PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:COLLCollegium Pharmaceutical Inc
08/12/20242:41PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
08/09/20244:34PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:COLLCollegium Pharmaceutical Inc
08/08/20244:04PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:COLLCollegium Pharmaceutical Inc
08/08/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
08/08/20244:01PMGlobeNewswire Inc.Collegium Reports Second Quarter 2024 Financial ResultsNASDAQ:COLLCollegium Pharmaceutical Inc
07/29/20246:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:COLLCollegium Pharmaceutical Inc
07/29/20246:00AMGlobeNewswire Inc.Collegium to Acquire Ironshore Therapeutics, Expanding into NeurologyNASDAQ:COLLCollegium Pharmaceutical Inc
07/25/20248:00AMGlobeNewswire Inc.Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:COLLCollegium Pharmaceutical Inc
 Showing the most relevant articles for your search:NASDAQ:COLL

Your Recent History

Delayed Upgrade Clock